Page last updated: 2024-11-08

2-c-methylerythritol 4-phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-C-methylerythritol 4-phosphate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID443198
CHEBI ID17764
SCHEMBL ID345740
MeSH IDM0294691

Synonyms (13)

Synonym
(2r,3s)-2,3,4-trihydroxy-3-methylbutyl dihydrogen phosphate
2-c-methyl-d-erythritol 4-(dihydrogen phosphate)
CHEBI:17764 ,
2-C-METHYL-D-ERYTHRITOL-4-PHOSPHATE ,
2-c-methyl-d-erythritol 4-phosphate
[(2r,3s)-2,3,4-trihydroxy-3-methylbutyl] dihydrogen phosphate
206440-72-4
2-c-methylerythritol 4-phosphate
methyl-d-erythritol phosphate
SCHEMBL345740
DTXSID90332064
Q2709086
1,2,3,4-butanetetrol, 2-methyl-, 4-(dihydrogen phosphate), (2s,3r)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
tetritol phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Methylerythritol phosphate pathway07
DXP pathway520

Research

Studies (223)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (1.79)18.2507
2000's95 (42.60)29.6817
2010's104 (46.64)24.3611
2020's20 (8.97)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.80 (24.57)
Research Supply Index5.43 (2.92)
Research Growth Index5.23 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews22 (9.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other205 (90.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]